Standard Biotools Inc
(LAB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 20,146 | 10,988 | 2,246 | -43,780 | -53,048 |
| Depreciation Amortization | 10,395 | 6,941 | 3,472 | 57,697 | 54,235 |
| Income taxes - deferred | 17,221 | 18,021 | 22,235 | -12,914 | 12,840 |
| Other Working Capital | 2,874 | -44,477 | -14,288 | -149,522 | -167,156 |
| Other Operating Activity | 2,330 | 1,998 | 1,157 | 21,960 | 22,018 |
| Operating Cash Flow | $52,966 | $-6,529 | $14,822 | $-126,559 | $-131,111 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -673 | -497 | -344 | -668 | -470 |
| Other Investing Activity | -325 | -325 | -325 | -340 | -340 |
| Investing Cash Flow | $-998 | $-822 | $-669 | $-1,008 | $-810 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 460,000 | 460,000 |
| Debt Repayment | -4,890 | -4,890 | -1,890 | -339,458 | -3,000 |
| Common Stock Issued | N/A | N/A | N/A | 1,375 | N/A |
| Dividend Paid | N/A | N/A | N/A | -3,448 | -3,448 |
| Other Financing Activity | -2,419 | -2,356 | -356 | -38,341 | -375,866 |
| Financing Cash Flow | $-7,309 | $-7,246 | $-2,246 | $80,128 | $77,686 |
| Beginning Cash Position | 444,446 | 444,446 | 444,446 | 491,885 | 491,885 |
| End Cash Position | 489,105 | 429,849 | 456,353 | 444,446 | 437,650 |
| Net Cash Flow | $44,659 | $-14,597 | $11,907 | $-47,439 | $-54,235 |
| Free Cash Flow | |||||
| Operating Cash Flow | 52,966 | -6,529 | 14,822 | -126,559 | -131,111 |
| Capital Expenditure | -673 | -497 | -344 | -668 | -470 |
| Free Cash Flow | 52,293 | -7,026 | 14,478 | -127,227 | -131,581 |